What are the benefits of TIL therapy?

TIL therapy is approved by the U.S. Food and Drug Administration for patients with advanced melanoma.

At UChicago Medicine, we are also testing TIL therapy in a clinical trial for patients with cervical cancer. Our physician-researchers also plan to study this treatment for other types of solid tumors in future clinical trials.